On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model. Posted byadmin 27. July 1998 Greil R, Egle A, Villunger A. http://www.ncbi.nlm.nih.gov/pubmed/9922038